Capital expenditure increased 62.4%
Capital expenditure changed +62.4% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +62.4% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Operating income changed +28.0% from the comparable as-filed period.
Net income changed +31.3% from the comparable as-filed period.
Cash & equivalents changed +46.1% from the comparable as-filed period.
Revenue changed +17.7% from the comparable as-filed period.
Free-cash-flow proxy changed -22.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Operating margin changed +122 basis points from the comparable as-filed period.
Capex / revenue changed +237 basis points from the comparable as-filed period.
Gross margin changed +129 basis points from the comparable as-filed period.
Operating cash flow changed +13.5% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Gross profit changed +21.6% from the comparable as-filed period.
Inventory changed +16.3% from the comparable as-filed period.
Inventory / revenue changed -192 basis points from the comparable as-filed period.
Selling, general & administrative changed +18.1% from the comparable as-filed period.
Stock-based compensation changed +22.7% from the comparable as-filed period.
SBC / revenue changed +3 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.